VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model March 7, 2022
NTLA-2002 shows promising preclinical results in a partial hepatectomy-induced HAE model March 3, 2022
Targeting MRGPRX2-mediated mast cell activation as a therapeutic strategy for atopic dermatitis March 1, 2022
Repertoire Immune Medicines and UMass Chan collaborate to understand immune causes of vitiligo Feb. 18, 2022
RSS